nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Carboplatin—bone cancer	0.117	0.195	CbGbCtD
Sumatriptan—ABCG2—Cisplatin—bone cancer	0.1	0.166	CbGbCtD
Sumatriptan—SLCO1A2—Methotrexate—bone cancer	0.0867	0.144	CbGbCtD
Sumatriptan—SLCO1B1—Methotrexate—bone cancer	0.0818	0.136	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—bone cancer	0.0671	0.112	CbGbCtD
Sumatriptan—ABCG2—Methotrexate—bone cancer	0.065	0.108	CbGbCtD
Sumatriptan—ABCB1—Cisplatin—bone cancer	0.0361	0.06	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—bone cancer	0.0242	0.0402	CbGbCtD
Sumatriptan—HTR1F—trigeminal nerve—bone cancer	0.0237	0.202	CbGeAlD
Sumatriptan—ABCB1—Methotrexate—bone cancer	0.0234	0.039	CbGbCtD
Sumatriptan—HTR1B—dura mater—bone cancer	0.0226	0.192	CbGeAlD
Sumatriptan—HTR1D—dura mater—bone cancer	0.0219	0.186	CbGeAlD
Sumatriptan—HTR1B—trigeminal nerve—bone cancer	0.00971	0.0827	CbGeAlD
Sumatriptan—HTR1D—trigeminal nerve—bone cancer	0.0094	0.0801	CbGeAlD
Sumatriptan—HTR3A—cranial nerve—bone cancer	0.00824	0.0703	CbGeAlD
Sumatriptan—HTR1B—cranial nerve—bone cancer	0.00692	0.0589	CbGeAlD
Sumatriptan—HTR1D—cranial nerve—bone cancer	0.0067	0.0571	CbGeAlD
Sumatriptan—HTR1D—connective tissue—bone cancer	0.00138	0.0118	CbGeAlD
Sumatriptan—MAOA—connective tissue—bone cancer	0.00105	0.00897	CbGeAlD
Sumatriptan—HTR1B—spinal cord—bone cancer	0.000946	0.00806	CbGeAlD
Sumatriptan—SLCO1A2—spinal cord—bone cancer	0.00089	0.00759	CbGeAlD
Sumatriptan—Almotriptan—CYP3A4—bone cancer	0.000863	0.562	CrCbGaD
Sumatriptan—HTR1A—spinal cord—bone cancer	0.000763	0.00651	CbGeAlD
Sumatriptan—MAOA—tendon—bone cancer	0.000723	0.00616	CbGeAlD
Sumatriptan—MAOA—spinal cord—bone cancer	0.000697	0.00594	CbGeAlD
Sumatriptan—Eletriptan—CYP3A4—bone cancer	0.000672	0.438	CrCbGaD
Sumatriptan—ABCG2—bone marrow—bone cancer	0.000607	0.00518	CbGeAlD
Sumatriptan—ABCG2—spinal cord—bone cancer	0.000605	0.00515	CbGeAlD
Sumatriptan—DRD2—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000349	0.00931	CbGpPWpGaD
Sumatriptan—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000306	0.00817	CbGpPWpGaD
Sumatriptan—ABCB1—bone marrow—bone cancer	0.000299	0.00255	CbGeAlD
Sumatriptan—ABCB1—spinal cord—bone cancer	0.000298	0.00254	CbGeAlD
Sumatriptan—Photosensitivity reaction—Methotrexate—bone cancer	0.000297	0.00123	CcSEcCtD
Sumatriptan—Angina pectoris—Epirubicin—bone cancer	0.000297	0.00123	CcSEcCtD
Sumatriptan—Decreased appetite—Cisplatin—bone cancer	0.000293	0.00121	CcSEcCtD
Sumatriptan—Bronchitis—Epirubicin—bone cancer	0.000293	0.00121	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Cisplatin—bone cancer	0.000291	0.0012	CcSEcCtD
Sumatriptan—Drowsiness—Methotrexate—bone cancer	0.00029	0.0012	CcSEcCtD
Sumatriptan—Depression—Methotrexate—bone cancer	0.00029	0.0012	CcSEcCtD
Sumatriptan—Pancytopenia—Epirubicin—bone cancer	0.00029	0.0012	CcSEcCtD
Sumatriptan—Gastritis—Doxorubicin—bone cancer	0.000289	0.00119	CcSEcCtD
Sumatriptan—Pain—Cisplatin—bone cancer	0.000289	0.00119	CcSEcCtD
Sumatriptan—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000288	0.00769	CbGpPWpGaD
Sumatriptan—Dysuria—Epirubicin—bone cancer	0.000285	0.00118	CcSEcCtD
Sumatriptan—HTR1D—G alpha (i) signalling events—GRM4—bone cancer	0.000285	0.0076	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—RGS1—bone cancer	0.000285	0.0076	CbGpPWpGaD
Sumatriptan—Abdominal distension—Doxorubicin—bone cancer	0.000284	0.00117	CcSEcCtD
Sumatriptan—Conjunctivitis—Methotrexate—bone cancer	0.000282	0.00117	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—bone cancer	0.000282	0.00116	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—bone cancer	0.000282	0.00116	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—bone cancer	0.000282	0.00116	CcSEcCtD
Sumatriptan—Pollakiuria—Epirubicin—bone cancer	0.000282	0.00116	CcSEcCtD
Sumatriptan—HTR1B—G alpha (i) signalling events—RGS1—bone cancer	0.000279	0.00744	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—GRM4—bone cancer	0.000279	0.00744	CbGpPWpGaD
Sumatriptan—Sweating—Methotrexate—bone cancer	0.000278	0.00115	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Epirubicin—bone cancer	0.000278	0.00115	CcSEcCtD
Sumatriptan—Feeling abnormal—Cisplatin—bone cancer	0.000278	0.00115	CcSEcCtD
Sumatriptan—Weight increased—Epirubicin—bone cancer	0.000277	0.00115	CcSEcCtD
Sumatriptan—Haematuria—Methotrexate—bone cancer	0.000277	0.00114	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—bone cancer	0.000277	0.00114	CcSEcCtD
Sumatriptan—Weight decreased—Epirubicin—bone cancer	0.000276	0.00114	CcSEcCtD
Sumatriptan—Hyperglycaemia—Epirubicin—bone cancer	0.000275	0.00114	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—bone cancer	0.000275	0.00113	CcSEcCtD
Sumatriptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000274	0.00733	CbGpPWpGaD
Sumatriptan—Epistaxis—Methotrexate—bone cancer	0.000274	0.00113	CcSEcCtD
Sumatriptan—Drowsiness—Epirubicin—bone cancer	0.000272	0.00112	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—bone cancer	0.000271	0.00112	CcSEcCtD
Sumatriptan—HTR1F—GPCR ligand binding—GRM4—bone cancer	0.000269	0.0072	CbGpPWpGaD
Sumatriptan—Pancytopenia—Doxorubicin—bone cancer	0.000268	0.00111	CcSEcCtD
Sumatriptan—Body temperature increased—Cisplatin—bone cancer	0.000267	0.0011	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—bone cancer	0.000264	0.00109	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—bone cancer	0.000264	0.00109	CcSEcCtD
Sumatriptan—Haemoglobin—Methotrexate—bone cancer	0.000262	0.00108	CcSEcCtD
Sumatriptan—Haemorrhage—Methotrexate—bone cancer	0.000261	0.00108	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—bone cancer	0.000261	0.00108	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—bone cancer	0.000261	0.00108	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—bone cancer	0.000259	0.00107	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—bone cancer	0.000257	0.00106	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—bone cancer	0.000257	0.00106	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—bone cancer	0.000256	0.00106	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—bone cancer	0.000255	0.00105	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—bone cancer	0.000255	0.00105	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—bone cancer	0.000254	0.00105	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—bone cancer	0.000252	0.00104	CcSEcCtD
Sumatriptan—Visual impairment—Methotrexate—bone cancer	0.000251	0.00104	CcSEcCtD
Sumatriptan—Hypersensitivity—Cisplatin—bone cancer	0.000249	0.00103	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—bone cancer	0.000248	0.00103	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—bone cancer	0.000245	0.00101	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—bone cancer	0.000244	0.00101	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—bone cancer	0.000244	0.00101	CcSEcCtD
Sumatriptan—Eye disorder—Methotrexate—bone cancer	0.000244	0.00101	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000243	0.0065	CbGpPWpGaD
Sumatriptan—Tinnitus—Methotrexate—bone cancer	0.000243	0.001	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—bone cancer	0.000243	0.001	CcSEcCtD
Sumatriptan—Asthenia—Cisplatin—bone cancer	0.000242	0.001	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—bone cancer	0.000241	0.000996	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—bone cancer	0.00024	0.00099	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—bone cancer	0.00024	0.00099	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—bone cancer	0.000237	0.000979	CcSEcCtD
Sumatriptan—Angiopathy—Methotrexate—bone cancer	0.000237	0.000977	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—bone cancer	0.000236	0.000974	CcSEcCtD
Sumatriptan—Immune system disorder—Methotrexate—bone cancer	0.000236	0.000972	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—bone cancer	0.000235	0.000971	CcSEcCtD
Sumatriptan—Mediastinal disorder—Methotrexate—bone cancer	0.000235	0.00097	CcSEcCtD
Sumatriptan—Chills—Methotrexate—bone cancer	0.000234	0.000966	CcSEcCtD
Sumatriptan—HTR1F—GPCR ligand binding—GRM1—bone cancer	0.000234	0.00624	CbGpPWpGaD
Sumatriptan—Diarrhoea—Cisplatin—bone cancer	0.000231	0.000954	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—bone cancer	0.00023	0.000949	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—bone cancer	0.000228	0.000942	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—bone cancer	0.000228	0.000939	CcSEcCtD
Sumatriptan—Erythema—Methotrexate—bone cancer	0.000227	0.000937	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—bone cancer	0.000227	0.000937	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—bone cancer	0.000226	0.000935	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—bone cancer	0.000226	0.000932	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—bone cancer	0.000225	0.000928	CcSEcCtD
Sumatriptan—Dysgeusia—Methotrexate—bone cancer	0.000222	0.000918	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—bone cancer	0.000222	0.000916	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—bone cancer	0.000221	0.000914	CcSEcCtD
Sumatriptan—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000221	0.00591	CbGpPWpGaD
Sumatriptan—Immune system disorder—Epirubicin—bone cancer	0.00022	0.00091	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—bone cancer	0.00022	0.000908	CcSEcCtD
Sumatriptan—Back pain—Methotrexate—bone cancer	0.00022	0.000907	CcSEcCtD
Sumatriptan—Chills—Epirubicin—bone cancer	0.000219	0.000904	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—bone cancer	0.000218	0.0009	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—bone cancer	0.000218	0.000898	CcSEcCtD
Sumatriptan—Vomiting—Cisplatin—bone cancer	0.000215	0.000886	CcSEcCtD
Sumatriptan—Rash—Cisplatin—bone cancer	0.000213	0.000879	CcSEcCtD
Sumatriptan—Dermatitis—Cisplatin—bone cancer	0.000213	0.000878	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—bone cancer	0.000212	0.000877	CcSEcCtD
Sumatriptan—HTR1A—G alpha (i) signalling events—RGS1—bone cancer	0.000212	0.00567	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—GRM4—bone cancer	0.000212	0.00567	CbGpPWpGaD
Sumatriptan—Eye disorder—Doxorubicin—bone cancer	0.000211	0.000871	CcSEcCtD
Sumatriptan—Ill-defined disorder—Methotrexate—bone cancer	0.000211	0.00087	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—bone cancer	0.000211	0.000869	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00021	0.00561	CbGpPWpGaD
Sumatriptan—Anaemia—Methotrexate—bone cancer	0.00021	0.000866	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—bone cancer	0.00021	0.000865	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—bone cancer	0.000209	0.000864	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—bone cancer	0.000208	0.000859	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—bone cancer	0.000205	0.000848	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—bone cancer	0.000205	0.000846	CcSEcCtD
Sumatriptan—Malaise—Methotrexate—bone cancer	0.000205	0.000845	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—bone cancer	0.000204	0.000843	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—bone cancer	0.000204	0.000842	CcSEcCtD
Sumatriptan—Vertigo—Methotrexate—bone cancer	0.000204	0.000842	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—bone cancer	0.000203	0.00084	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—bone cancer	0.000203	0.000836	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—bone cancer	0.000202	0.000833	CcSEcCtD
Sumatriptan—Nausea—Cisplatin—bone cancer	0.000201	0.000828	CcSEcCtD
Sumatriptan—Cough—Methotrexate—bone cancer	0.000198	0.000818	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—bone cancer	0.000197	0.000814	CcSEcCtD
Sumatriptan—Convulsion—Methotrexate—bone cancer	0.000197	0.000812	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—bone cancer	0.000197	0.000812	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—bone cancer	0.000196	0.000811	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—bone cancer	0.000195	0.000806	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—bone cancer	0.000194	0.0008	CcSEcCtD
Sumatriptan—Myalgia—Methotrexate—bone cancer	0.000193	0.000798	CcSEcCtD
Sumatriptan—Arthralgia—Methotrexate—bone cancer	0.000193	0.000798	CcSEcCtD
Sumatriptan—Chest pain—Methotrexate—bone cancer	0.000193	0.000798	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—bone cancer	0.000192	0.000795	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—bone cancer	0.000192	0.000791	CcSEcCtD
Sumatriptan—Discomfort—Methotrexate—bone cancer	0.000191	0.000788	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—bone cancer	0.000191	0.000788	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—bone cancer	0.00019	0.000787	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—bone cancer	0.00019	0.000785	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—bone cancer	0.000189	0.00078	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—bone cancer	0.000188	0.000775	CcSEcCtD
Sumatriptan—Confusional state—Methotrexate—bone cancer	0.000187	0.000771	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—bone cancer	0.000187	0.000771	CcSEcCtD
Sumatriptan—DRD2—G alpha (i) signalling events—GRM4—bone cancer	0.000186	0.00498	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—RGS1—bone cancer	0.000186	0.00498	CbGpPWpGaD
Sumatriptan—Cough—Epirubicin—bone cancer	0.000185	0.000765	CcSEcCtD
Sumatriptan—Anaphylactic shock—Methotrexate—bone cancer	0.000185	0.000765	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—bone cancer	0.000184	0.00076	CcSEcCtD
Sumatriptan—Infection—Methotrexate—bone cancer	0.000184	0.00076	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—bone cancer	0.000183	0.000757	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—bone cancer	0.000182	0.000753	CcSEcCtD
Sumatriptan—Nervous system disorder—Methotrexate—bone cancer	0.000182	0.00075	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—bone cancer	0.000182	0.00075	CcSEcCtD
Sumatriptan—Thrombocytopenia—Methotrexate—bone cancer	0.000181	0.000749	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—bone cancer	0.000181	0.000747	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—bone cancer	0.000181	0.000747	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—bone cancer	0.000181	0.000747	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—bone cancer	0.000181	0.000746	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—bone cancer	0.00018	0.000744	CcSEcCtD
Sumatriptan—Skin disorder—Methotrexate—bone cancer	0.00018	0.000743	CcSEcCtD
Sumatriptan—Hyperhidrosis—Methotrexate—bone cancer	0.000179	0.000739	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—bone cancer	0.000179	0.000738	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—bone cancer	0.000177	0.000732	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—bone cancer	0.000177	0.00073	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—bone cancer	0.000177	0.000729	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—bone cancer	0.000176	0.000728	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—bone cancer	0.000175	0.000722	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—bone cancer	0.000174	0.000717	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—bone cancer	0.000173	0.000716	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—bone cancer	0.000173	0.000716	CcSEcCtD
Sumatriptan—Hypotension—Methotrexate—bone cancer	0.000173	0.000715	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—bone cancer	0.000173	0.000713	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—GRM4—bone cancer	0.000172	0.0046	CbGpPWpGaD
Sumatriptan—Infection—Epirubicin—bone cancer	0.000172	0.000711	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—bone cancer	0.000172	0.000708	CcSEcCtD
Sumatriptan—Shock—Epirubicin—bone cancer	0.000171	0.000704	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—bone cancer	0.00017	0.000703	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—bone cancer	0.00017	0.000702	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—bone cancer	0.00017	0.000701	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—bone cancer	0.00017	0.000701	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—bone cancer	0.000169	0.000699	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000169	0.000697	CcSEcCtD
Sumatriptan—HTR1B—GPCR ligand binding—GRM4—bone cancer	0.000169	0.00451	CbGpPWpGaD
Sumatriptan—Skin disorder—Epirubicin—bone cancer	0.000168	0.000695	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—bone cancer	0.000168	0.000692	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—bone cancer	0.000167	0.000691	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—bone cancer	0.000167	0.000691	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—bone cancer	0.000167	0.000691	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—bone cancer	0.000167	0.000689	CcSEcCtD
Sumatriptan—Paraesthesia—Methotrexate—bone cancer	0.000166	0.000687	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—bone cancer	0.000165	0.000683	CcSEcCtD
Sumatriptan—Dyspnoea—Methotrexate—bone cancer	0.000165	0.000682	CcSEcCtD
Sumatriptan—Somnolence—Methotrexate—bone cancer	0.000165	0.00068	CcSEcCtD
Sumatriptan—HTR1F—GPCR ligand binding—SMO—bone cancer	0.000165	0.0044	CbGpPWpGaD
Sumatriptan—Dry mouth—Doxorubicin—bone cancer	0.000164	0.000676	CcSEcCtD
Sumatriptan—MAOA—Biological oxidations—CYP3A4—bone cancer	0.000162	0.00434	CbGpPWpGaD
Sumatriptan—Hypotension—Epirubicin—bone cancer	0.000162	0.000669	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—bone cancer	0.000162	0.000668	CcSEcCtD
Sumatriptan—Decreased appetite—Methotrexate—bone cancer	0.000161	0.000665	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—bone cancer	0.00016	0.000662	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—bone cancer	0.00016	0.000662	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Methotrexate—bone cancer	0.00016	0.00066	CcSEcCtD
Sumatriptan—Fatigue—Methotrexate—bone cancer	0.00016	0.000659	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—bone cancer	0.000159	0.000658	CcSEcCtD
Sumatriptan—Pain—Methotrexate—bone cancer	0.000158	0.000654	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000158	0.000652	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—bone cancer	0.000158	0.000652	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—bone cancer	0.000157	0.00065	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—bone cancer	0.000157	0.000648	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—bone cancer	0.000157	0.000646	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—bone cancer	0.000156	0.000643	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—bone cancer	0.000156	0.000643	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—bone cancer	0.000155	0.00064	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—bone cancer	0.000155	0.000638	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—bone cancer	0.000154	0.000636	CcSEcCtD
Sumatriptan—Feeling abnormal—Methotrexate—bone cancer	0.000153	0.00063	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—GRM4—bone cancer	0.000152	0.00407	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—RGS1—bone cancer	0.000152	0.00407	CbGpPWpGaD
Sumatriptan—Gastrointestinal pain—Methotrexate—bone cancer	0.000151	0.000625	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—bone cancer	0.000151	0.000622	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—bone cancer	0.00015	0.000619	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—bone cancer	0.00015	0.000618	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—bone cancer	0.000149	0.000617	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—GRM1—bone cancer	0.000149	0.00399	CbGpPWpGaD
Sumatriptan—Constipation—Epirubicin—bone cancer	0.000148	0.000612	CcSEcCtD
Sumatriptan—Pain—Epirubicin—bone cancer	0.000148	0.000612	CcSEcCtD
Sumatriptan—Urticaria—Methotrexate—bone cancer	0.000147	0.000608	CcSEcCtD
Sumatriptan—Body temperature increased—Methotrexate—bone cancer	0.000146	0.000605	CcSEcCtD
Sumatriptan—Abdominal pain—Methotrexate—bone cancer	0.000146	0.000605	CcSEcCtD
Sumatriptan—HTR1B—GPCR ligand binding—GRM1—bone cancer	0.000146	0.00391	CbGpPWpGaD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000146	0.000603	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—bone cancer	0.000144	0.000595	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—bone cancer	0.000143	0.00059	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—bone cancer	0.000143	0.00059	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—bone cancer	0.000143	0.000589	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—bone cancer	0.000142	0.000585	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—bone cancer	0.000139	0.000576	CcSEcCtD
Sumatriptan—MAOA—Biological oxidations—GSTP1—bone cancer	0.000139	0.00371	CbGpPWpGaD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000138	0.000572	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—bone cancer	0.000138	0.000571	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—GRM4—bone cancer	0.000138	0.00369	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—RGS1—bone cancer	0.000138	0.00369	CbGpPWpGaD
Sumatriptan—Urticaria—Epirubicin—bone cancer	0.000138	0.000569	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—bone cancer	0.000137	0.000566	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—bone cancer	0.000137	0.000566	CcSEcCtD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000137	0.00366	CbGpPWpGaD
Sumatriptan—ABCG2—Fluoropyrimidine Activity—TP53—bone cancer	0.000137	0.00366	CbGpPWpGaD
Sumatriptan—Abdominal pain—Epirubicin—bone cancer	0.000137	0.000566	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—bone cancer	0.000137	0.000566	CcSEcCtD
Sumatriptan—Hypersensitivity—Methotrexate—bone cancer	0.000136	0.000564	CcSEcCtD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000134	0.00359	CbGpPWpGaD
Sumatriptan—Asthenia—Methotrexate—bone cancer	0.000133	0.000549	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—bone cancer	0.000132	0.000546	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—GRM1—bone cancer	0.000132	0.00353	CbGpPWpGaD
Sumatriptan—Gastrointestinal pain—Doxorubicin—bone cancer	0.000131	0.000542	CcSEcCtD
Sumatriptan—Pruritus—Methotrexate—bone cancer	0.000131	0.000541	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—GRM4—bone cancer	0.000129	0.00343	CbGpPWpGaD
Sumatriptan—Hypersensitivity—Epirubicin—bone cancer	0.000128	0.000527	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—bone cancer	0.000127	0.000526	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—bone cancer	0.000127	0.000524	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—bone cancer	0.000127	0.000524	CcSEcCtD
Sumatriptan—Diarrhoea—Methotrexate—bone cancer	0.000127	0.000523	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—bone cancer	0.000124	0.000514	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—bone cancer	0.000123	0.000506	CcSEcCtD
Sumatriptan—Dizziness—Methotrexate—bone cancer	0.000123	0.000506	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—GRM1—bone cancer	0.00012	0.0032	CbGpPWpGaD
Sumatriptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.00012	0.00319	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000119	0.00319	CbGpPWpGaD
Sumatriptan—Diarrhoea—Epirubicin—bone cancer	0.000119	0.00049	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—bone cancer	0.000118	0.000488	CcSEcCtD
Sumatriptan—DRD2—Circadian rythm related genes—GNA11—bone cancer	0.000118	0.00315	CbGpPWpGaD
Sumatriptan—Vomiting—Methotrexate—bone cancer	0.000118	0.000486	CcSEcCtD
Sumatriptan—DRD2—Circadian rythm related genes—EZH2—bone cancer	0.000117	0.00314	CbGpPWpGaD
Sumatriptan—Rash—Methotrexate—bone cancer	0.000117	0.000482	CcSEcCtD
Sumatriptan—Dermatitis—Methotrexate—bone cancer	0.000117	0.000482	CcSEcCtD
Sumatriptan—Headache—Methotrexate—bone cancer	0.000116	0.000479	CcSEcCtD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000116	0.0031	CbGpPWpGaD
Sumatriptan—Asthenia—Doxorubicin—bone cancer	0.000115	0.000475	CcSEcCtD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000115	0.00307	CbGpPWpGaD
Sumatriptan—Dizziness—Epirubicin—bone cancer	0.000115	0.000473	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—bone cancer	0.000113	0.000469	CcSEcCtD
Sumatriptan—DRD2—GPCR ligand binding—GRM4—bone cancer	0.000113	0.00301	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—GRM1—bone cancer	0.000111	0.00298	CbGpPWpGaD
Sumatriptan—Vomiting—Epirubicin—bone cancer	0.00011	0.000455	CcSEcCtD
Sumatriptan—Nausea—Methotrexate—bone cancer	0.00011	0.000454	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—bone cancer	0.00011	0.000453	CcSEcCtD
Sumatriptan—Rash—Epirubicin—bone cancer	0.000109	0.000451	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—bone cancer	0.000109	0.000451	CcSEcCtD
Sumatriptan—Headache—Epirubicin—bone cancer	0.000109	0.000448	CcSEcCtD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000106	0.00284	CbGpPWpGaD
Sumatriptan—Dizziness—Doxorubicin—bone cancer	0.000106	0.000438	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—SMO—bone cancer	0.000105	0.00281	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NDUFA12—bone cancer	0.000105	0.00281	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—SMO—bone cancer	0.000103	0.00275	CbGpPWpGaD
Sumatriptan—Nausea—Epirubicin—bone cancer	0.000103	0.000425	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—bone cancer	0.000102	0.000421	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—bone cancer	0.000101	0.000418	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—bone cancer	0.000101	0.000417	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—bone cancer	0.0001	0.000415	CcSEcCtD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.92e-05	0.00265	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—GRM1—bone cancer	9.78e-05	0.00261	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.78e-05	0.00261	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—GRM4—bone cancer	9.74e-05	0.0026	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—RGS1—bone cancer	9.74e-05	0.0026	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NDUFA12—bone cancer	9.73e-05	0.0026	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—GRM4—bone cancer	9.53e-05	0.00255	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—RGS1—bone cancer	9.53e-05	0.00255	CbGpPWpGaD
Sumatriptan—Nausea—Doxorubicin—bone cancer	9.53e-05	0.000393	CcSEcCtD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—TUBB2A—bone cancer	9.18e-05	0.00245	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NDUFA12—bone cancer	8.98e-05	0.0024	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—RGS1—bone cancer	8.84e-05	0.00236	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—GRM4—bone cancer	8.84e-05	0.00236	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NT5C3A—bone cancer	8.7e-05	0.00233	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—RGS1—bone cancer	8.66e-05	0.00231	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—GRM4—bone cancer	8.66e-05	0.00231	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—GNA11—bone cancer	8.51e-05	0.00227	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—SMO—bone cancer	8.45e-05	0.00226	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—GRM1—bone cancer	8.44e-05	0.00226	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	8.32e-05	0.00222	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NDUFA12—bone cancer	8.32e-05	0.00222	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—GRM1—bone cancer	8.27e-05	0.00221	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RGS1—bone cancer	8.17e-05	0.00218	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GRM4—bone cancer	8.17e-05	0.00218	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NT5C3A—bone cancer	8.06e-05	0.00215	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	7.89e-05	0.00211	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—SMO—bone cancer	7.85e-05	0.0021	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—GNA11—bone cancer	7.73e-05	0.00206	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—IL3—bone cancer	7.71e-05	0.00206	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—GRM1—bone cancer	7.67e-05	0.00205	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.57e-05	0.00202	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—GRM1—bone cancer	7.51e-05	0.00201	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NT5C3A—bone cancer	7.44e-05	0.00199	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—RGS1—bone cancer	7.26e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GRM4—bone cancer	7.26e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GRM1—bone cancer	7.08e-05	0.00189	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	7.01e-05	0.00187	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL3—bone cancer	7e-05	0.00187	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.9e-05	0.00184	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—SMO—bone cancer	6.89e-05	0.00184	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NT5C3A—bone cancer	6.89e-05	0.00184	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.8e-05	0.00182	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—CDK4—bone cancer	6.63e-05	0.00177	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	6.61e-05	0.00177	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—RGS1—bone cancer	6.6e-05	0.00176	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GRM4—bone cancer	6.6e-05	0.00176	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.45e-05	0.00172	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GRM4—bone cancer	6.38e-05	0.0017	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—RGS1—bone cancer	6.38e-05	0.0017	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GRM1—bone cancer	6.3e-05	0.00168	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—BRAF—bone cancer	6.05e-05	0.00162	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—JUN—bone cancer	5.96e-05	0.00159	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GRM4—bone cancer	5.79e-05	0.00155	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—RGS1—bone cancer	5.79e-05	0.00155	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.77e-05	0.00154	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.75e-05	0.00154	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GRM1—bone cancer	5.72e-05	0.00153	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GRM1—bone cancer	5.53e-05	0.00148	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—GNA11—bone cancer	5.44e-05	0.00145	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—SMO—bone cancer	5.4e-05	0.00144	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—GNA11—bone cancer	5.33e-05	0.00142	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—SMO—bone cancer	5.29e-05	0.00141	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RGS1—bone cancer	5.22e-05	0.0014	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GRM4—bone cancer	5.22e-05	0.0014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RGS1—bone cancer	5.11e-05	0.00137	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GRM4—bone cancer	5.11e-05	0.00137	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—MDM2—bone cancer	5.07e-05	0.00135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GRM1—bone cancer	5.02e-05	0.00134	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SMO—bone cancer	4.99e-05	0.00133	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.96e-05	0.00133	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—GNA11—bone cancer	4.94e-05	0.00132	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL3—bone cancer	4.93e-05	0.00132	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—GNA11—bone cancer	4.84e-05	0.00129	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL3—bone cancer	4.83e-05	0.00129	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—GNA11—bone cancer	4.56e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GRM1—bone cancer	4.53e-05	0.00121	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NDUFA12—bone cancer	4.5e-05	0.0012	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL3—bone cancer	4.48e-05	0.0012	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GRM1—bone cancer	4.43e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL3—bone cancer	4.39e-05	0.00117	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.28e-05	0.00114	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—JUN—bone cancer	4.27e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ATF1—bone cancer	4.24e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL3—bone cancer	4.14e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GNA11—bone cancer	4.06e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—SMO—bone cancer	4.03e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GRM4—bone cancer	3.9e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RGS1—bone cancer	3.9e-05	0.00104	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ENO2—bone cancer	3.81e-05	0.00102	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NT5C3A—bone cancer	3.73e-05	0.000995	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GNA11—bone cancer	3.68e-05	0.000985	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL3—bone cancer	3.68e-05	0.000983	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GNA11—bone cancer	3.56e-05	0.000952	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TGFBR2—bone cancer	3.54e-05	0.000945	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—SMO—bone cancer	3.54e-05	0.000945	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—DHFR—bone cancer	3.54e-05	0.000945	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ENO2—bone cancer	3.53e-05	0.000944	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RGS1—bone cancer	3.42e-05	0.000914	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRM4—bone cancer	3.42e-05	0.000914	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GRM1—bone cancer	3.38e-05	0.000903	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL3—bone cancer	3.34e-05	0.000893	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1R—bone cancer	3.33e-05	0.000889	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GNA11—bone cancer	3.3e-05	0.000883	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—DHFR—bone cancer	3.28e-05	0.000875	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ENO2—bone cancer	3.26e-05	0.000871	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GNA11—bone cancer	3.24e-05	0.000864	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL3—bone cancer	3.23e-05	0.000863	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SMO—bone cancer	3.19e-05	0.000853	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.17e-05	0.000847	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SMO—bone cancer	3.12e-05	0.000835	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GNA11—bone cancer	3.06e-05	0.000818	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.06e-05	0.000817	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—DHFR—bone cancer	3.02e-05	0.000808	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ENO2—bone cancer	3.02e-05	0.000806	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP3A4—bone cancer	3e-05	0.000801	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.98e-05	0.000796	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRM1—bone cancer	2.97e-05	0.000792	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL3—bone cancer	2.93e-05	0.000784	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GNA11—bone cancer	2.92e-05	0.00078	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GNA11—bone cancer	2.86e-05	0.000763	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GNA11—bone cancer	2.83e-05	0.000755	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—bone cancer	2.82e-05	0.000754	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—DHFR—bone cancer	2.8e-05	0.000748	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP3A4—bone cancer	2.78e-05	0.000742	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.76e-05	0.000736	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ATF1—bone cancer	2.71e-05	0.000725	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ATF1—bone cancer	2.66e-05	0.00071	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL3—bone cancer	2.65e-05	0.000707	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GNA11—bone cancer	2.62e-05	0.000699	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL3—bone cancer	2.59e-05	0.000692	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTP1—bone cancer	2.56e-05	0.000685	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP3A4—bone cancer	2.56e-05	0.000685	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.55e-05	0.000681	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KIT—bone cancer	2.41e-05	0.000645	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SMO—bone cancer	2.38e-05	0.000636	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTP1—bone cancer	2.37e-05	0.000634	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP3A4—bone cancer	2.37e-05	0.000634	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BRAF—bone cancer	2.27e-05	0.000606	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TGFBR2—bone cancer	2.26e-05	0.000605	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TGFBR2—bone cancer	2.22e-05	0.000592	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—bone cancer	2.2e-05	0.000588	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTP1—bone cancer	2.19e-05	0.000586	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GNA11—bone cancer	2.18e-05	0.000582	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.17e-05	0.000579	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1R—bone cancer	2.13e-05	0.000569	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SMO—bone cancer	2.09e-05	0.000558	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1R—bone cancer	2.08e-05	0.000557	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTP1—bone cancer	2.03e-05	0.000542	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ATF1—bone cancer	2.02e-05	0.000541	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL3—bone cancer	1.97e-05	0.000527	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GNA11—bone cancer	1.91e-05	0.000511	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MDM2—bone cancer	1.9e-05	0.000508	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.82e-05	0.000486	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ATF1—bone cancer	1.78e-05	0.000475	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL3—bone cancer	1.73e-05	0.000463	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TGFBR2—bone cancer	1.69e-05	0.000451	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—JUN—bone cancer	1.65e-05	0.000442	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ENO2—bone cancer	1.63e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MMP9—bone cancer	1.61e-05	0.00043	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1R—bone cancer	1.59e-05	0.000424	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KIT—bone cancer	1.54e-05	0.000413	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DHFR—bone cancer	1.51e-05	0.000404	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KIT—bone cancer	1.51e-05	0.000404	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TGFBR2—bone cancer	1.48e-05	0.000396	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—bone cancer	1.45e-05	0.000388	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—bone cancer	1.42e-05	0.00038	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GNA11—bone cancer	1.41e-05	0.000378	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—bone cancer	1.41e-05	0.000376	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1R—bone cancer	1.39e-05	0.000373	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—bone cancer	1.38e-05	0.000368	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—bone cancer	1.33e-05	0.000355	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—bone cancer	1.3e-05	0.000347	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP3A4—bone cancer	1.28e-05	0.000343	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—bone cancer	1.23e-05	0.000329	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MDM2—bone cancer	1.22e-05	0.000325	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MDM2—bone cancer	1.19e-05	0.000318	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KIT—bone cancer	1.15e-05	0.000308	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—bone cancer	1.14e-05	0.000303	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTP1—bone cancer	1.1e-05	0.000293	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—bone cancer	1.09e-05	0.000292	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—bone cancer	1.08e-05	0.000289	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—JUN—bone cancer	1.06e-05	0.000282	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—bone cancer	1.05e-05	0.000281	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.05e-05	0.00028	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—JUN—bone cancer	1.03e-05	0.000277	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MMP9—bone cancer	1.03e-05	0.000275	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KIT—bone cancer	1.01e-05	0.00027	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MMP9—bone cancer	1.01e-05	0.000269	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—bone cancer	9.5e-06	0.000254	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—bone cancer	9.21e-06	0.000246	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MDM2—bone cancer	9.07e-06	0.000242	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—bone cancer	8.31e-06	0.000222	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—bone cancer	8.14e-06	0.000217	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MDM2—bone cancer	7.96e-06	0.000213	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—JUN—bone cancer	7.88e-06	0.000211	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MMP9—bone cancer	7.67e-06	0.000205	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—bone cancer	6.98e-06	0.000186	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—JUN—bone cancer	6.92e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—bone cancer	6.83e-06	0.000183	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MMP9—bone cancer	6.73e-06	0.00018	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—bone cancer	6.2e-06	0.000166	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—bone cancer	5.68e-06	0.000152	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—bone cancer	5.44e-06	0.000145	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—bone cancer	5.2e-06	0.000139	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—bone cancer	4.57e-06	0.000122	CbGpPWpGaD
